Sporadic reports have documented the use in countries such as Brazil and Mozambique of misoprostol to self-induce pregnancy termination (PT). This paper presents the case of a young woman from Mozambique who presented to a UK surgery requesting PT . She stated she was concerned about medication she had taken for epigastric pain in early pregnancy. She reluctantly acknowledged the medication was misoprostol obtained from a friend from Portugal. The patient had taken a total dose of 1000 mcg of misoprostol on the same day. After counseling on the potential adverse effects of misoprostol during pregnancy specifically miscarriage and fetal abnormalities the woman accepted but later declined a referral for induced abortion. She gave birth to a healthy infant. There is concern that the access to medical information from unregulated sources through the Internet will increase the potentially dangerous use of misoprostol as an abortifacient.